SCA
IDYA icon

Snowden Capital Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Snowden Capital Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Sell
17,281
-1,950
-10% -$59.7K 0.02% 736
2026
Q1 		$641K Buy
19,231
+1,671
+10% +$56.1K 0.02% 689
2025
Q4 		$607K Sell
17,560
-166
-0.9% -$5.29K 0.02% 711
2025
Q3 		$482K Buy
17,726
+4,095
+30% +$99K 0.01% 795
2025
Q2 		$287K Buy
13,631
+2,328
+21% +$44.7K 0.01% 1027
2025
Q1 		$185K Sell
11,303
-336
-3% -$7.16K 0.01% 1166
2024
Q4 		$299K Sell
11,639
-77
-0.7% -$2.18K 0.01% 987
2024
Q3 		$371K Buy
11,716
+442
+4% +$16.8K 0.01% 902
2024
Q2 		$396K Buy
+11,274
New +$446K 0.01% 860

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Snowden Capital Advisors's IDYA Position: Q2 2026 in Review

Snowden Capital Advisors reduced its IDEAYA Biosciences (IDYA) stake by 10% in Q2 2026, selling an estimated $59.7K and leaving 17,281 shares worth $644K. The position accounts for 0.02% of the portfolio, ranked #736.

Snowden Capital Advisors first reported a position in IDYA in Q2 2024 and has held it in 9 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Snowden Capital Advisors held 17,281 shares of IDEAYA Biosciences worth $644K as of Q2 2026.
  • Snowden Capital Advisors sold 1,950 IDEAYA Biosciences shares in Q2 2026, an estimated $59.7K.
  • IDEAYA Biosciences made up 0.02% of Snowden Capital Advisors's portfolio in Q2 2026, its #736 holding.
  • Snowden Capital Advisors first reported a position in IDEAYA Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.